Qiagen N.V.
QGEN NYSEHealthcare ★★★★★Latest Earnings
Date
Aug 5, 2026
ET
EPS Est.
0.60
EPS Actual
0.62
Revenue Est.
$527.5M
Revenue Actual
$535M
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
0.63
Revenue Est.
$535.9M
Company Overview
Qiagen N.V. (ticker QGEN) is listed on NYSE with a market cap of about $9.09B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), After-market, with consensus EPS of 0.63. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Feb 7, 2023 → Aug 5, 2026
Feb 7, 2023Range: 0.46 ~ 0.64Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | 0.60 | 0.62 | $527.5M | $535M |
| May 6, 2026 | -- | 0.54 | 0.54 | $496.1M | $492.3M |
| Feb 4, 2026 | -- | 0.61 | 0.62 | $528.4M | $540.4M |
| Nov 4, 2025 | -- | 0.61 | 0.64 | $525.9M | $532.6M |
| Aug 5, 2025 | -- | 0.60 | 0.60 | $515.8M | $533.5M |
| May 7, 2025 | -- | 0.50 | 0.55 | $468.9M | $483.5M |
| Feb 5, 2025 | -- | 0.60 | 0.61 | $518.5M | $521.2M |
| Nov 6, 2024 | -- | 0.54 | 0.57 | $491.7M | $502.6M |
| Jul 31, 2024 | -- | 0.53 | 0.57 | $491.7M | $496.3M |
| Apr 29, 2024 | -- | 0.44 | 0.46 | $457.3M | $458.8M |
| Feb 6, 2024 | -- | 0.55 | 0.55 | $500.2M | $509.2M |
| Oct 30, 2023 | -- | 0.52 | 0.53 | $469.8M | $475.9M |
| Aug 8, 2023 | -- | 0.53 | 0.54 | $492.5M | $494.9M |
| May 3, 2023 | -- | 0.50 | 0.54 | $480.5M | $485.4M |
| Feb 7, 2023 | -- | 0.50 | 0.56 | $489.9M | $498M |
Original Filings (SEC)
6-K2026-08-07 ↗
6-K2026-08-07 ↗
6-K2026-08-07 ↗
6-K2026-05-08 ↗
6-K2026-05-08 ↗
20-F2026-03-20 ↗
6-K2026-02-06 ↗
6-K2025-12-22 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
